Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni

Parasitology Research

Volumn 107, Issue 3, 2010, Pages 531-538

  Neves, Juliana Kelle De Andrade Lemoine ^a,c   Botelho, Sandra Paula Sarinho ^a   De Melo, Cristiane Moutinho Lagos ^b   Pereira, Valéria Rêgo Alves ^b   De Lima, Maria Do Carmo Alves ^a   Da Rocha Pitta, Ivan ^a   De Azevedo Albuquerque, Mônica Camelo Pessoa ^a   Lins Galdino, Suely ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

5 [4 CHLOROBENZYLIDENE 3 (4 NITREBENZYL)] 4 THIOXOIMIDAZOLIDIN 2 ONE; 5 [4 FLUORIDE BENZYLIDENE 3 (4 NITREBENZYL)] 4 THIOXOIMIDAZOLIDIN 2 ONE; GAMMA INTERFERON; IMIDAZOLIDINE DERIVATIVE; INTERLEUKIN 10; NITRIC OXIDE; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; IC 50; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; TOXICITY TESTING;

ANIMALS; FEMALE; IMIDAZOLIDINES; MALE; MICE; MICE, INBRED BALB C; PARASITIC SENSITIVITY TESTS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES;

SCHISTOSOMA MANSONI;

EID: 77955472197     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-010-1886-y     Document Type: Article

References (37)

1. SF Ahmed IP Oswald P Caspar S Hieny SL Keefer SL James 1997 Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni Infect Immun 65 219 226 1:CAS:528:DyaK2sXhvVyktA%3D%3D 8975915
2. MCA Albuquerque TG Silva MGR Pitta ACA Silva PG Silva E Malagueño JV Santana AG Wanderley MCA Lima SL Galdino J Barbe IR Pitta 2005 Synthesis and schistosomicidal activity of new substituted thioxoimidazolidine compounds Pharmazie 60 13 17 1:CAS:528:DC%2BD2MXotlWqtQ%3D%3D 15700773
3. HA Badreldin 2006 A short review of some pharmacological, therapeutic and toxicological properties of praziquantel in man and animals Pak J Pharm Sci 19 170 175
4. PM Brophy DI Pritchard 1992 Immunity to helminths: ready to tip the biochemical balance? Parasitol Today 8 419 422 10.1016/0169-4758(92)90195-8 1:CAS:528:DyaK3sXhsVGiu7Y%3D 15463560
5. LR Brunet 2001 Nitric oxide in parasitic infections Int Immunopharmcol 1 1457 1467 10.1016/S1567-5769(01)00090-X 1:CAS:528:DC%2BD3MXlvFSmt74%3D (Pubitemid 32622790)
6. MC Caterina IA Perillo L Boiani H Pezaroglo H Cerecetto M Gonzalez A Salerno 2008 Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships Bioorg Med Chem 16 2226 2234 10.1016/j.bmc.2007.11.077 1:CAS:528:DC%2BD1cXjtl2mtb8%3D 18083035 (Pubitemid 351380953)
7. BG Chand US Ray G Mostafa J Cheng TH Lu C Sinha 2005 Difference in bonding behaviour of azide and thiocyanate to Hg (II)-azoimidazoles Inorg Chim Acta 358 1927 1933 10.1016/j.ica.2004.12.046 1:CAS:528:DC%2BD2MXhvF2lu7o%3D (Pubitemid 40347263)
8. L Chitsulo D Engels A Montreso L Savioli 2000 The global status of schistosomiasis and its control Acta Trop 77 41 51 10.1016/S0001-706X(00)00122-4 1:STN:280:DC%2BD3cvksleltg%3D%3D 10996119
9. D Cioli L Pica-Mattoccia 2003 Praziquantel Parasitol Res 90 3 9
10. M Colasanti L Gradoni M Mattu T Persichini L Salvati G Venturini P Ascenzi 2002 Molecular basis for the anti-parasitic effect on NO Int J Mol Med 9 131 134 1:CAS:528:DC%2BD38Xht1ymurc%3D 11786922
11. R Corrêa-Oliveira IR Caldas OA Martins-Filho CC Queiroz JR Lambertucci JR Cunha-Melo AS Silveira A Prata A Wilson G Gazzinelli 2000 Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas Acta Trop 77 141 146 10.1016/S0001-706X(00)00127-3 10996129
12. JF Curtin M Donovan TG Cotter 2002 Regulation and measurement of oxidative stress in apoptosis J Immunol Met 265 49 72 10.1016/S0022-1759(02) 00070-4 1:CAS:528:DC%2BD38XksFKgtbw%3D (Pubitemid 34628804)
13. AD Dayan 2003 Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics Acta Trop 86 141 159 10.1016/S0001-706X(03)00031-7 1:CAS:528:DC%2BD3sXjs1CksLc%3D 12745134 (Pubitemid 36561365)
14. AH Ding CF Nathan D Stuehr 1988 Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production J Immunol 141 2407 2412 1:CAS:528:DyaL1cXmtV2ns7s%3D 3139757
15. Dubois, et al. 2009 Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni Mol Biochem Parasitol 168 7 15 10.1016/j.molbiopara.2009.06.001 1:CAS:528:DC%2BD1MXhtVehsr3F 19538992
16. Grevelding GC (2004) Schistosoma. Institute for Genetics, Heinrich-Heine-University, 40225 Düsseldorf, Germany. Magazine R545
17. KF Hoffmann TA Wynn DW Dunne 2002 Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology Adv Parasitol 52 265 10.1016/S0065-308X(02)52014-5 12521263 (Pubitemid 36069926)
18. M Ismail S Botros A Metwally S William A Farghally LF Ta TA Day JL Bennett 1999 Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers Am J Trop Med Hyg 60 932 935 1:CAS:528:DyaK1MXksVyjtbo%3D 10403323
19. SL James J Glaven 1989 Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates J Immunol 143 4208 4212 1:CAS:528:DyaK3cXhtlOht7k%3D 2592772
20. N Kalyaham PC Sparthasarathy L Ananthan SG Manjunatha MA Likhate 1992 Studies on antiamoebic compounds. Iv: synthesis of hexahydropyrimidines and tetrahydroimidazoles Indian J Chem Sect B 31 243 247
21. R Korhonen O Kosonen M Hämäläinen E Moilanen 2008 Nitric oxide-releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes Bas Clin Pharmacol Toxicol 103 322 328 10.1111/j.1742-7843.2008.00275.x 1:CAS:528:DC%2BD1cXht1GmtrjE
22. Korolkovas A (1974) Fundamentos de farmacologia molecular: base para o planejamento de fármacos. Editora da Universidade de São Paulo, São Paulo
23. SVP Malheiros MA Brito D Brites NC Meirelles 2000 Membrane effects of trifluoperazine, dibucaine and praziquantel on human erythrocytes Chem-Biol Inter 126 79 95 10.1016/S0009-2797(00)00150-2 1:CAS:528:DC%2BD3cXktFCnt78%3D (Pubitemid 30336359)
24. RJ Martin 1997 Mode of action of anthelminitic drugs Vet J 154 11 34 10.1016/S1090-0233(05)80005-X 1:CAS:528:DyaK2sXmsValsbo%3D 9265850 (Pubitemid 27371230)
25. S Moncada RMJ Palmer EA Higgs 1991 Nitric oxide: physiology, pathophysiology and pharmacology Pharmacol Rev 43 109 142 1:CAS:528: DyaK3MXmt1amtLw%3D 1852778
26. SM Oliveira MCPA Albuquerque MGR Pitta E Malagueño JV Santana MCA Lima IR Pitta SL Galdino 2004 A resposta do Schistosoma mansoni mantido in vitro frente a derivados imidazolidinônicos Acta Farm Bonaer 23 343 348 1:CAS:528:DC%2BD2cXhtVCkt7jF
27. L Oliver MA Stirewalt 1952 An efficient method for exposure of mice to cercariae of Schistosoma mansoni J Parasitol 38 19 23 10.2307/3274166
28. VRA Pereira VMB Lorena AP Galvão da Silva EM Coutinho ED Silva AGP Ferreira P Miranda MA Krieger S Goldenberg MBP Soares R Correa-Oliveira Y Gomes 2004 Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi stimulates a cellular immune response in mice Parasitol 129 563 570 10.1017/S0031182004006043 1:CAS:528:DC%2BD2cXotFSgsL8%3D (Pubitemid 39473006)
29. L Pica-Mattoccia D Cioli 2004 Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment Int J Parasitol 34 527 533 10.1016/j.ijpara.2003.12.003 1:CAS:528:DC%2BD2cXhvFSmsL0%3D 15013742 (Pubitemid 38317176)
30. MGR Pitta ACA Silva JKAL Neves PG Silva JI Irmão E Malagueño JV Santana MCA Lima SL Galdino IR Pitta MCPA Albuquerque 2006 New imidazolidinic bioisosters: potential candidates for antischistosomal drugs Mem Inst Osw Cruz 101 313 316 1:CAS:528:DC%2BD28Xht1ertb7O
31. G Rai AA Sayed H Lea A Wendy F Luecke H Chakrapani S Prast-Nielsen A Jadhav W Leister I Min A James P Christopher LA Keefer SJ Elias A Simeonov DJ Maloney DL Williams TJ Craig 2009 Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis J Med Chem 52 6474 6483 10.1021/jm901021k 1:CAS:528:DC%2BD1MXhtFCqtb7K 19761212
32. A Rivero 2006 Nitric oxide: an antiparasitic molecule of invertebrates Trends Parasitol 22 219 225 10.1016/j.pt.2006.02.014 1:CAS:528: DC%2BD28XksFaks7Y%3D 16545612
33. MH Rossi R Zelnik 2000 Contribuição à química das imidazolidinadionas-Síntese de ciclanilideno-hidantoínas Arq Inst Biol 1 67
34. AA Sayed A Simeonov CJ Thomas J Inglese CP Austin DL Williams 2008 Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat Med 14 407 412 10.1038/nm1737 1:CAS:528:DC%2BD1cXktl2isLw%3D 18345010 (Pubitemid 351499390)
35. V Sharma MSY Khan 2001 Synthesis of novel tetrahydroimidazole derivatives and studies for their biological properties Eur J Med Chem 36 651 10.1016/S0223-5234(01)01256-9 1:CAS:528:DC%2BD3MXnsVKktr8%3D 11600234 (Pubitemid 32964735)
36. GF Wiegertjes M Forlenza M Joerink JP Scharsack 2005 Parasite infections revisited Dev Comp Immunol 29 749 10.1016/j.dci.2005.01.005 15936432 (Pubitemid 40776064)
37. SH Xiao BA Catto LT Webster 1985 Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo J Infect Dis 151 1130 1137 1:CAS:528:DyaL2MXlsFegtLw%3D 3998507